Select Page

Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease

Shift Health has led a study showing that we are systematically underestimating the global socioeconomic burden of Alzheimer’s disease. The hidden costs have important implications for policymakers.

More

Medical Cannabis

Driven by emerging clinical evidence and increasingly favourable regulatory conditions, companies are racing to develop cannabis-based pharmaceuticals for diverse indications. In this paper, we explore three trends that we believe will critically shape the cannabis industry over the coming years.

More

Product Development 101

Shift Health partnered with the Global HIV Vaccine Enterprise to pilot a two-day Boot Camp aimed at educating vaccine development partners across sectors—academia, government, funders, NGOs, industry—on strategies, tools and best practices enabling product development.

More

Product Development Partnerships

Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. Ryan Wiley, PhD, President at Shift Health, delivered an overview of product development partnerships.

More